J&J Stock Sinks After Revenue Misses and Full-year Outlook Was Cut, as Drug Sales Disappoint

Jason Ware, Partner & Chief Investment Officer at Albion Financial Group, talks about the growth prospects for the healthcare industry and highlights areas in the market that are undervalued.

Apr 20, 2022

More Videos

Markets React to Fed Cut: Citi on Earnings, AI Spending, and the Road to 2026

Citi’s Drew Pettit breaks down how the Fed’s latest rate cut is reshaping equity markets, earnings expectations and sector strategy.

Inside Wealthfront’s Big IPO Moment and the Future of Robo Banks

Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."

Go Fund Yourself: Two Brands Redefining the Future of Sustainable

Power of 3re redefines renewable energy through recycling innovation. THC Grow pioneers sustainable cultivation with tech-driven transparency.

Disney's Former Head of Innovation and Creativity on How to Be Inspired at Work

Duncan Wardle, former Head of Innovation and Creativity at Disney, explains how to execute new, imaginative ideas within massive corporate enterprises

NASA Roboticist on the Emotional Connection Between Humans and Machines

Ayanna Howard, NASA roboticist and Dean of Engineering at OSU, explains integrating human emotion with AI at World Business Forum

Inside the Fed’s Decision to Cut Rates

The Fed cut rates, sparking market swings. Bill Mann unpacks the decision, the economy’s direction, policy risks, and what investors should know.

America’s Chipmaking Comeback: Why the U.S. Is Racing to Reshore Semiconductors

The Verge’s Senior Science Reporter, Justine Calma, explains how the Chips Act and federal funding are reshaping America’s chipmaking future.

The Hybrid Work Revolution: Why Mark Dixon Says the Office Will Never Be the Same

Mark Dixon shares how IWG supports companies through hybrid work, RTO shifts, and the next era of flexible workspaces.

Trending Now